Developing Medicines in Line with Global Public Health Needs: The Role of the World Health Organization

2011 ◽  
Vol 20 (2) ◽  
pp. 290-297 ◽  
Author(s):  
TIKKI PANG

“I want my leadership to be judged by the impact of our work on the health of two populations: women and the people of Africa.” This is how Dr. Margaret Chan, the current Director-General of the World Health Organization (WHO), described her leadership mission. The reason behind this mission is evident. Women and girls constitute 70% of the world’s poor and 80% of the world’s refugees. Gender violence against women aged 15–44 is responsible for more deaths and disability than cancer, malaria, traffic accidents, and war. An estimated 350,000 to 500,000 women still die in childbirth every year. The negative health implications of absolute poverty are worst in Sub-Saharan Africa and South Asia. Hence, Chan aims to have the biggest impact on the world’s poorest people.

2019 ◽  
Vol 3 ◽  
pp. 1546 ◽  
Author(s):  

Taenia solium (TS), responsible for porcine cysticercosis, human taeniasis and (neuro)cysticercosis, was included in the World Health Organization neglected tropical disease (NTD) roadmap published in 2012. Targets set in this roadmap have not been met, but T. solium has been included in the consultation process for the new 2030 goals proposed for priority NTDs. Taenia solium transmission dynamics models can contribute to this process. A recent review has compared existing T. solium transmission models, identifying their similarities and differences in structure, parameterization and modelled intervention approaches. While a formal model comparison to investigate the impact of interventions is yet to be conducted, the models agree on the importance of coverage for intervention effectiveness and on the fact that human- and pig-focused interventions can be optimally combined. One of these models, cystiSim, an individual-based, stochastic model has been used to assess field-applicable interventions, some currently under evaluation in on-going trials in Zambia. The EPICYST, population-based, deterministic model has highlighted, based on simulating a generic sub-Saharan Africa setting, the higher efficacy (measured as the percentage of human cysticercosis cases prevented) of biomedical interventions (human and pig treatment and pig vaccination) compared to improved husbandry, sanitation, and meat inspection. Important questions remain regarding which strategies and combinations thereof provide sustainable solutions for severely resource-constrained endemic settings. Defining realistic timeframes to achieve feasible targets, and establishing suitable measures of effectiveness for these targets that can be quantified with current monitoring and evaluation tools, are current major barriers to identifying validated strategies. Taenia solium transmission models can support setting achievable 2030 goals; however, the refinement of these models is first required. Incorporating socio-economic elements, improved understanding of underlying biological processes, and consideration of spatial dynamics are key knowledge gaps that need addressing to support model development.


2019 ◽  
Vol 3 ◽  
pp. 1546 ◽  
Author(s):  

Taenia solium (TS), responsible for porcine cysticercosis, human taeniasis and (neuro)cysticercosis, was included in the World Health Organization neglected tropical disease (NTD) roadmap published in 2012. Targets set in this roadmap have not been met, but T. solium has been included in the consultation process for the new 2030 goals proposed for priority NTDs. Taenia solium transmission dynamics models can contribute to this process. A recent review has compared existing T. solium transmission models, identifying their similarities and differences in structure, parameterization and modelled intervention approaches. While a formal model comparison to investigate the impact of interventions is yet to be conducted, the models agree on the importance of coverage for intervention effectiveness and on the fact that human- and pig-focused interventions can be optimally combined. One of these models, cystiSim, an individual-based, stochastic model has been used to assess field-applicable interventions, some currently under evaluation in on-going trials in Zambia. The EPICYST, population-based, deterministic model has highlighted, based on simulating a generic sub-Saharan Africa setting, the higher efficacy (measured as the percentage of human cysticercosis cases prevented) of biomedical interventions (human and pig treatment and pig vaccination) compared to improved husbandry, sanitation, and meat inspection. Important questions remain regarding which strategies and combinations thereof provide sustainable solutions for severely resource-constrained endemic settings. Defining realistic timeframes to achieve feasible targets, and establishing suitable measures of effectiveness for these targets that can be quantified with current monitoring and evaluation tools, are current major barriers to identifying validated strategies. Taenia solium transmission models can support setting achievable 2030 goals; however, the refinement of these models is first required. Incorporating socio-economic elements, improved understanding of underlying biological processes, and consideration of spatial dynamics are key knowledge gaps that need addressing to support model development.


Author(s):  
Nicholas Spence ◽  
Jerry P. White

On June 11, 2009, the Director General of the World Health Organization, Dr. Margaret Chan, announced that the scientific evidence indicated that the criteria for an influenza pandemic had been met: pandemic H1N1/09 virus, the first in nearly 40 years, was officially upon us. The World Health Organization has estimated that as many as 2 billion or between 15 and 45 percent of the population globally will be infected by the H1N1/09 virus. Scientists and governments have been careful to walk a line between causing mass public fear and ensuring people take the risks seriously. The latest information indicates that the majority of individuals infected with the H1N1/09 virus thus far have suffered mild illness, although very severe and fatal illness have been observed in a small number of cases, even in young and healthy people (World Health Organization 2009c). There is no evidence to date that the virus has mutated to a more virulent or lethal form; however, as we enter the second wave of the pandemic, a significant number of people in countries across the world are susceptible to infection. Most importantly, certain subgroups have been categorized as high risk given the clinical evidence to date. One of these subgroups is Indigenous populations (World Health Organization 2009c).


2014 ◽  
Vol 18 (1) ◽  
pp. 405-424
Author(s):  
Pia Acconci

The World Health Organization (who) was established in 1946 as a specialized agency of the United Nations (un). Since its establishment, the who has managed outbreaks of infectious diseases from a regulatory, as well as an operational perspective. The adoption of the International Health Regulations (ihrs) has been an important achievement from the former perspective. When the Ebola epidemic intensified in 2014, the who Director General issued temporary recommendations under the ihrs in order to reduce the spread of the disease and minimize cross-border barriers to international trade. The un Secretary General and then the Security Council and the General Assembly have also taken action against the Ebola epidemic. In particular, the Security Council adopted a resolution under Chapter vii of the un Charter, and thus connected the maintenance of the international peace and security to the health and social emergency. After dealing with the role of the who as a guide and coordinator of the reaction to epidemics, this article shows how the action by the Security Council against the Ebola epidemic impacts on the who ‘authority’ for the protection of health.


2020 ◽  
Vol 17 (1) ◽  
pp. 261-290 ◽  
Author(s):  
Steven A. Solomon ◽  
Claudia Nannini

Participation in the World Health Organization (WHO) is a multifaceted matter and should be understood as not only referring to the governance of WHO, but also to its scientific and technical work as well as its collaborative efforts towards advancing global public health more generally. The article is concerned, in particular, with the legal and political framework surrounding attendance and participation of states and various entities in the governing bodies of the Organization, at the global and regional level. It shows that participation in the governance of WHO is still today a domain reserved to the determination of its Member States. At the same time, solutions have been found and continued efforts are necessary to take into account geopolitical considerations and to ensure a meaningful and inclusive participation of all relevant actors in global health discussions.


1949 ◽  
Vol 3 (3) ◽  
pp. 546-548

On March 22, 1949 Costa Rica ratified the constitution of the World Health Organization and on April 13 WHO was joined by Honduras, thus bringing the membership of the organization to 61.The agreement by which the Pan American Sanitary Organization became the regional office for WHO in the western hemisphere was signed on May 24, 1949 in Washington by Dr. Brock Chisholm, Director General of WHO and Dr. Fred L. Soper, Director of the Pan American Sanitary Office. Under the agreement the office was to adopt and promote health and sanitary conventions and programs in the western hemisphere provided they were “compatible with the policy and programs of the World Health Organization and are separately financed.”


1958 ◽  
Vol 12 (3) ◽  
pp. 391-394 ◽  

The Executive Board of the World Health Organization (WHO) held its 21st session in Geneva, January 14–28, 1958, under the chairmanship of Sir John Charles. After discussing in detail the Director-General's proposed program of activities and budget estimates for 1959, the Board endorsed the Director-General's effective working budget of$14, 287, 600. It was suggested that in preparing the 1960 budget a greater percentage of the total expenditure should be set aside for strengthening the technical services at headquarters. In pursuance of WHO's policy of complete malaria eradication, the Director-General had drawn up a detailed program covering the operations for the following five years. Noting that the total resources available in the malaria eradication special account amounted to $5,112,000, and that the estimated expenditure for 1958 alone was $5,058,000, the Board expressed the hope that governments able to do so would make voluntary contributions to the account and requested the Director-General to take the necessary steps, including adequate publicity, to obtain additional funds, whether from governmental or from private sources.


It’s been a while since Coronavirus disease (COVID-19) was characterized as a pandemic by the World Health Organization (WHO), causing major concerns and unfortunately panic in many countries. The on-going outbreak is of international concern and most countries have already announced a series of protective measures to confront this health threat of unknown magnitude. Travel warnings, scientific congress suspensions, cancellations of national holidays and closing of schools, amusement parks, cinemas, theatres and gyms are only some of these measures. The impact in sports is also tremendous. Major sport events like the 2020 Tokyo Olympic Games and Euro 2020 have been postponed. Others like the Miami Open and the Wimbledon tennis tournament have been cancelled and there is an ongoing discussion for forthcoming events. However, few have been said regarding the impact of limiting public exercise.


Sign in / Sign up

Export Citation Format

Share Document